Capital Investment Advisory Services’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-9,474
Closed -$224K – 899
2022
Q4
$224K Buy
+9,474
New +$255K 0.03% 431
2022
Q1
– Sell
-2,413
Closed -$222K – 887
2021
Q4
$222K Sell
2,413
-1,473
-38% -$176K 0.03% 448
2021
Q3
$493K Sell
3,886
-208
-5% -$30.3K 0.06% 270
2021
Q2
$681K Sell
4,094
-26
-0.6% -$4.21K 0.09% 225
2021
Q1
$749K Buy
4,120
+161
+4% +$37.3K 0.11% 186
2020
Q4
$792K Buy
3,959
+2,884
+268% +$586K 0.12% 177
2020
Q3
$236K Buy
+1,075
New +$228K 0.04% 318
2019
Q4
– Sell
-450
Closed -$30K – 1175
2019
Q3
$30K Buy
450
+400
+800% +$26.3K 0.01% 691
2019
Q2
$4K Hold
50
– – ﹤0.01% 1189
2019
Q1
$3K Buy
+50
New +$3.05K ﹤0.01% 1072

Other funds holding TDOC

Capital Investment Advisory Services's TDOC Position: Q1 2023 in Review

Capital Investment Advisory Services sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 9,474 shares — an estimated $224K sold.

Capital Investment Advisory Services first reported a position in TDOC in Q1 2019 and held it in 10 quarters. The position peaked at $792K in Q4 2020. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

  • Capital Investment Advisory Services reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
  • Capital Investment Advisory Services sold 9,474 Teladoc Health shares in Q1 2023, an estimated $224K.
  • Capital Investment Advisory Services first reported a position in Teladoc Health in Q1 2019 and held it in 10 quarters.
  • Capital Investment Advisory Services's Teladoc Health position peaked at $792K in Q4 2020.
  • 429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on Capital Investment Advisory Services's 13F filing for Q1 2023, filed 21 Apr 2023.